News

HIV Cure Research Advances and the New IAS Global Scientific Strategy: Towards an HIV Cure 2016 will headline the 21st International AIDS Conference (AIDS 2016) in Durban (Durban, SOUTH AFRICA) -- Sixteen years ago, the historic 13th International AIDS Conference inspired a new paradigm for HIV treatment access that helped change the trajectory of the global AIDS epidemic. This year, as 18,000 scientists, policymakers, advocates and people living with HIV return to Durban, South Africa, AIDS 20...

Published in Nature Medicine, the IAS Global Scientific Strategy: Towards an HIV Cure 2016 Is a Roadmap for Researchers, Donors, and Stakeholders Working to Achieve HIV Cure or Remission

We are delighted to welcome Carlo Oliveras to the International AIDS Society (IAS) as the new Programme Coordinator for the Adolescent HIV Treatment Coalition (ATC) hosted by CIPHER. The ATC collaborates with networks of people living with HIV, HIV treatment organizations, youth organizations – including young people living with HIV – researchers, clinicians and global health agencies to fill urgent gaps in addressing the treatment and care needs of adolescents living with HIV. Previously, ...

The International AIDS Society (IAS) welcomes the Global Health Sector Strategies and congratulates the World Health Organization (WHO) on the broad- based consultation - particularly the engagement of civil society partners who are key players in supporting their realisation. HIV, viral hepatitis and STIs are major public health issues and an integrated client-centred approach within a framework of universal health coverage will strengthen achievement of the Sustainable Development Goals (SDGs)...

The International AIDS Society (IAS) is pleased to announce the results of the 2016 IAS Governing Council Elections. We would like to thank the members for your commitment and engagement in the elections. A total of 1,675 votes were received, which means that 22.1% of all members eligible to vote participated in the elections. The following IAS members were elected – using the Single Transferable Vote electoral system – and will serve on the IAS Governing Council for the next four years.   ...

The International AIDS Society (IAS) is grateful to Dr. Jack Whitescarver for his lifetime of dedication in the fight against HIV and AIDS and his more than twenty years as a member of the IAS. Dr. Whitescarver has announced that he will step down as Director of the Office of AIDS Research at the National Institutes of Health (NIH) in the United States as of 1 July 2015. He has held the position since 2000. During his NIH tenure, Dr. Whitescarver launched visionary domestic and international re...

An international commission of medical experts is calling for global drug decriminalisation, arguing that current policies lead to violence, deaths and the spread of disease, harming health and human rights.

The world has lost one of its most dedicated leaders in the fight against HIV. The International AIDS Society (IAS) shares in the deep sadness felt by many at the loss of Dr. Willard (Ward) Cates. For over 40 years, Ward has been working in the field of women's health, reproductive rights, and HIV/AIDS and was a recognised force in linking these fields of work. Ward was beloved as a committed and humble mentor to new generations of scientists and researchers. He was a true pioneer, an extraordi...

We are delighted to welcome Kevin Osborne to the International AIDS Society (IAS) as the new Director of HIV Programmes and Advocacy. Kevin brings over twenty years of experience in public health to the IAS executive team with a background in HIV programme implementation and human rights. Kevin has supported a number of national, regional and international programmes by forging sustainable partnerships with governments, UN agencies, community organisations and the donor community. He has extens...

Common Material Transfer Agreement will accelerate the search for a cure 20 January 2016 (Geneva, Switzerland)– The International AIDS Society (IAS) today announced the finalisation of a Common Material Transfer Agreement (cMTA) for the donation and use of antiretroviral drugs for preclinical studies in HIV cure research. This major achievement is the result of more than a year of negotiation with leading pharmaceutical companies. “This agreement will greatly accelerate the transfer of drugs...